A carregar...
Indacaterol, a once‐daily beta(2)‐agonist, versus twice‐daily beta(2)‐agonists or placebo for chronic obstructive pulmonary disease
BACKGROUND: Indacaterol is an inhaled long‐acting beta(2)‐agonist that is administered once daily and has been investigated as a treatment for chronic obstructive pulmonary disease (COPD). Four different doses have been investigated (75 mcg, 150 mcg, 300 mcg and 600 mcg). The relative effects of dif...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464646/ https://ncbi.nlm.nih.gov/pubmed/25575340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010139.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|